• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[1989 - 2008年中国肝癌在性别、地理区域及诊断平均年龄方面的发病率差异]

[The incidence differences among sex, geographical areas and mean age of diagnosis for liver cancer in China, 1989-2008].

作者信息

Zhang Siwei, Zheng Rongshou, Zeng Hongmei, Chen Wanqing

机构信息

National Cancer Center, National Center for Cancer Registries, Beijing 100021, China.

National Cancer Center, National Center for Cancer Registries, Beijing 100021, China. Email:

出版信息

Zhonghua Yu Fang Yi Xue Za Zhi. 2014 May;48(5):355-60.

PMID:24985372
Abstract

OBJECTIVE

Using the incidence data from 1989 to 2008 of liver cancer from population in cancer registration areas in China, the differences and changes of gender, urban and rural areas for liver cancer incidence in different years were studied, and the mean age of incidence was analyzed.

METHODS

The incidence data of liver cancer from National Cancer Registration database were sorted and checked. A total of 181 097 new liver cancer cases were collected, covering 711 843 051 person years from 1989 to 2008.Using Poisson regression model, Stratified by gender and areas, changes of incidence gender ratio, ratio of urban and rural, and mean age were analyzed.

RESULTS

After adjusting the age, the liver cancer incidence in male was about 3 times higher than that in females (ranging from 2.64-3.54), and the ratio change between male and female for the 20 years did not have statistically significant (P = 0.150). The incidence ratio between urban and rural areas has increased from 0.51 in 1989 to 0.61 in 2008 (P < 0.01). The mean ages of diagnosis for male and female increased from 57.14 years to 60.34 years, 61.69 years to 66.47 years, respectively from 1989 to 2008. The mean age of liver cancer diagnosis has increased in the 20 years (P < 0.01).

CONCLUSION

The liver cancer incidence between male and female did not change significantly among 20 years. The difference of liver cancer incidence between urban and rural areas has reduced, and the mean age of diagnosis was deferred.

摘要

目的

利用中国癌症登记地区1989年至2008年人群肝癌发病数据,研究不同年份肝癌发病的性别、城乡差异及变化情况,并分析发病年龄均值。

方法

整理并核查国家癌症登记数据库中的肝癌发病数据。共收集到181097例肝癌新发病例,覆盖1989年至2008年711843051人年。采用泊松回归模型,按性别和地区分层,分析发病性别比、城乡比及平均年龄的变化。

结果

调整年龄后,男性肝癌发病率约为女性的3倍(范围为2.64 - 3.54),20年间男女发病率之比变化无统计学意义(P = 0.150)。城乡发病率之比从1989年的0.51升至2008年的0.61(P < 0.01)。1989年至2008年,男性和女性的诊断平均年龄分别从57.14岁增至60.34岁、从61.69岁增至66.47岁。20年间肝癌诊断平均年龄有所增加(P < 0.01)。

结论

20年间男女肝癌发病率无显著变化。城乡肝癌发病率差异缩小,诊断平均年龄推迟。

相似文献

1
[The incidence differences among sex, geographical areas and mean age of diagnosis for liver cancer in China, 1989-2008].[1989 - 2008年中国肝癌在性别、地理区域及诊断平均年龄方面的发病率差异]
Zhonghua Yu Fang Yi Xue Za Zhi. 2014 May;48(5):355-60.
2
[Incidence and mortality of liver cancer in China: an analysis on data from the National Registration System between 2003 and 2007].中国肝癌的发病率与死亡率:基于2003年至2007年国家登记系统数据的分析
Zhonghua Liu Xing Bing Xue Za Zhi. 2012 Jun;33(6):547-53.
3
[Trend analysis and prediction of cancer incidence in China].[中国癌症发病率的趋势分析与预测]
Zhonghua Yu Fang Yi Xue Za Zhi. 2012 Jul;46(7):581-6.
4
[Analysis and prediction of liver cancer incidence in China].[中国肝癌发病率的分析与预测]
Zhonghua Yu Fang Yi Xue Za Zhi. 2012 Jul;46(7):587-92.
5
[Analysis and prediction of esophageal cancer incidence trend in China].[中国食管癌发病趋势的分析与预测]
Zhonghua Yu Fang Yi Xue Za Zhi. 2012 Jul;46(7):593-7.
6
[Analysis and prediction of breast cancer incidence trend in China].[中国乳腺癌发病趋势分析与预测]
Zhonghua Yu Fang Yi Xue Za Zhi. 2012 Aug;46(8):703-7.
7
Rural-urban, sex variations, and time trend of primary liver cancer incidence in China, 1988-2005.中国 1988-2005 年原发性肝癌发病率的城乡、性别差异和时间趋势。
Eur J Cancer Prev. 2013 Sep;22(5):448-54. doi: 10.1097/CEJ.0b013e32835de82a.
8
[The incidence and mortality trends of female breast cancer in Beijing, China: between 2004 and 2008].[2004年至2008年中国北京女性乳腺癌的发病率和死亡率趋势]
Zhonghua Yu Fang Yi Xue Za Zhi. 2012 Nov;46(11):1009-14.
9
[Trend analysis and projection of cancer incidence in China between 1989 and 2008].1989年至2008年间中国癌症发病率的趋势分析与预测
Zhonghua Zhong Liu Za Zhi. 2012 Jul;34(7):517-24. doi: 10.3760/cma.j.issn.0253-3766.2012.07.010.
10
[Incidence and mortality of oral cavity and pharyngeal cancer in China, 2009].2009年中国口腔和咽癌的发病率与死亡率
Zhonghua Yu Fang Yi Xue Za Zhi. 2013 Jul;47(7):586-91.

引用本文的文献

1
Recent trends in the incidence and survival of stage I liver cancer: a surveillance, epidemiology, and end results analysis.近期 I 期肝癌发病率和生存率的变化趋势:监测、流行病学和最终结果分析。
Ann Med. 2022 Dec;54(1):2785-2795. doi: 10.1080/07853890.2022.2131328.
2
Prognostic risk factor analysis and nomogram construction for primary liver cancer in elderly patients based on SEER database.基于 SEER 数据库的老年原发性肝癌预后风险因素分析及列线图构建
BMJ Open. 2022 Oct 26;12(10):e051946. doi: 10.1136/bmjopen-2021-051946.
3
A nomogram to predict prognosis after surgery for young patients with hepatocellular carcinoma.
一种用于预测年轻肝细胞癌患者手术后预后的列线图。
Transl Cancer Res. 2021 Apr;10(4):1773-1786. doi: 10.21037/tcr-20-3411.
4
The Age-Specific Features and Clinical Significance of NRF2 and MAPK10 Expression in HCC Patients.肝癌患者中NRF2和MAPK10表达的年龄特异性特征及临床意义
Int J Gen Med. 2022 Jan 20;15:737-748. doi: 10.2147/IJGM.S351263. eCollection 2022.
5
Prognostic gene biomarker identification in liver cancer by data mining.通过数据挖掘鉴定肝癌的预后基因生物标志物
Am J Transl Res. 2021 May 15;13(5):4603-4613. eCollection 2021.
6
Disease burden of liver cancer in China from 1997 to 2016: an observational study based on the Global Burden of Diseases.1997年至2016年中国肝癌的疾病负担:一项基于全球疾病负担的观察性研究
BMJ Open. 2019 Apr 23;9(4):e025613. doi: 10.1136/bmjopen-2018-025613.
7
Association of p53 codon 72 polymorphism with susceptibility to hepatocellular carcinoma in a Chinese population from northeast Sichuan.p53基因密码子72多态性与川东北人群肝细胞癌易感性的关联
Biomed Rep. 2017 Feb;6(2):217-222. doi: 10.3892/br.2017.840. Epub 2017 Jan 11.
8
Prognostic value of the expression of cancer stem cell-related markers CD133 and CD44 in hepatocellular carcinoma: From patients to patient-derived tumor xenograft models.癌症干细胞相关标志物CD133和CD44的表达在肝细胞癌中的预后价值:从患者到患者来源的肿瘤异种移植模型
Oncotarget. 2016 Jul 26;7(30):47431-47443. doi: 10.18632/oncotarget.10164.